Stericycle (SRCL) Stock Price, News & Analysis

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last twelve months. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SRCL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SRCL, but not buy additional shares or sell existing shares.
View SRCL analyst ratings or view top-rated stocks.

4 equities research analysts have issued 12 month price targets for Stericycle's shares. Their SRCL share price targets range from $48.00 to $75.00. On average, they predict the company's stock price to reach $62.25 in the next year. This suggests a possible upside of 25.6% from the stock's current price.
View analysts price targets for SRCL or view top-rated stocks among Wall Street analysts.

Stericycle's stock was trading at $49.56 at the start of the year. Since then, SRCL shares have increased by 0.0% and is now trading at $49.56.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our SRCL earnings forecast.

Stericycle, Inc. (NASDAQ:SRCL) announced its earnings results on Wednesday, February, 28th. The business services provider reported $0.54 earnings per share for the quarter, beating analysts' consensus estimates of $0.47 by $0.07. The business services provider had revenue of $652 million for the quarter, compared to analysts' expectations of $657.99 million. Stericycle had a positive trailing twelve-month return on equity of 7.06% and a negative net margin of 0.80%. The business's quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.60 earnings per share.

ETFs with the largest weight of Stericycle (NASDAQ:SRCL) stock in their portfolio include VanEck Environmental Services ETF (EVX), VanEck Green Infrastructure ETF (RNEW), iShares Environmental Infrastructure and Industrials ETF (EFRA), QRAFT AI-Enhanced U.S. Next Value ETF (NVQ), First Trust Utilities AlphaDEX Fund (FXU) and iShares U.S. Utilities ETF (IDU).Pacer BioThreat Strategy ETF (VIRS) and

Stericycle issued an update on its FY24 earnings guidance on Tuesday, March, 5th. The company provided EPS guidance of $2.20-2.50 for the period, compared to the consensus estimate of $2.34.

132 employees have rated Stericycle Chief Executive Officer Cindy Miller on Glassdoor.com. Cindy Miller has an approval rating of 74% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stericycle investors own include Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), QUALCOMM (QCOM), Johnson & Johnson (JNJ), AbbVie (ABBV), Fastenal (FAST) and Gilead Sciences (GILD).

Stericycle's stock is owned by a variety of retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.60%), Perpetual Ltd (0.30%), State of Michigan Retirement System (0.02%), Park Avenue Securities LLC (0.01%), Park Place Capital Corp (0.00%) and GAMMA Investing LLC (0.00%). Insiders that own company stock include Daniel Ginnetti, Naren K Gursahaney and Stephen Cory White.
View institutional ownership trends.

Shares of SRCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.